Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,013,985,374
+$1,849,055,895 QoQ
Shares Held
19,925,232
+36.9% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#13
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. ABBV ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,013,985,374 | 19,925,232 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,164,929,479 | 14,552,069 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,400,274,841 | 14,881,504 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,369,231,148 | 14,551,400 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,804,323,006 | 15,107,871 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,702,351,229 | 17,670,634 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,064,774,125 | 17,246,900 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,739,786,960 | 13,873,744 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $2,736,521,837 | 15,954,535 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,029,749,784 | 11,146,347 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,173,229,050 | 7,570,685 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,077,986,413 | 7,231,896 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $959,439,946 | 7,121,205 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $1,288,181,169 | 8,082,959 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,748,596,275 | 10,819,852 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,586,780,929 | 11,823,120 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,963,776,926 | 12,821,735 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,296,824,565 | 14,168,309 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,683,229,512 | 19,817,057 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,787,104,721 | 16,567,208 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,874,708,854 | 16,643,367 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,003,463,018 | 9,272,436 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $509,541,211 | 4,755,401 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $520,915,767 | 5,947,206 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $671,844,753 | 6,842,990 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $308,838,220 | 4,053,527 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||